Table 1.
Patient characteristics
|
All patients |
hs-cTnT ≤14 ng/L |
hs-cTnT > 14 ng/L |
p value | |
|---|---|---|---|---|
| (n = 287) | (n = 131) | (n = 156) | ||
| Age (y) |
76 (65–83) |
65 (59–76) |
81 (74–87) |
<0.001 |
| Females |
129 (44.9) |
59 (45.0) |
70 (44.9) |
0.977 |
|
Medical history: | ||||
| Cerebrovascular disease |
61 (21.3) |
18 (13.7) |
43 (27.6) |
0.004 |
| Coronary heart disease |
72 (25.1) |
15 (11.5) |
57 (36.5) |
<0.001 |
| Congestive heart failure |
33 (11.5) |
4 (3.1) |
29 (18.6) |
<0.001 |
| Atrial fibrillation |
79 (27.5) |
20 (15.3) |
59 (37.8) |
<0.001 |
| Diabetes mellitus |
39 (13.6) |
10 (7.6) |
29 (18.6) |
0.007 |
| Smoking |
53 (18.5) |
36 (27.5) |
17 (10.9) |
<0.001 |
| Hypertension |
179 (62.4) |
67 (51.1) |
112 (71.8) |
<0.001 |
| Hyperlipidemia |
86 (30.0) |
35 (26.7) |
51 (32.7) |
0.271 |
|
Vital signs: | ||||
| Pulse |
77.4 (±17.3) |
76.8 (±15.1) |
78.0 (±19.0) |
0.818 |
| Systolic BP |
165.9 (±30.3) |
167.9 (±29.5) |
164.3 (±30.9) |
0.337 |
| Diastolic BP |
87.1 (±15.0) |
88.1 (±13.2) |
86.2 (±16.3) |
0.152 |
| NIHSS |
4 (2-9) |
3 (1-7) |
4 (2-12) |
0.001 |
| rt-PA |
27 (9.4) |
21 (16.0) |
6 (3.8) |
<0.001 |
| Blood leukocyte count (109/L) |
7.6 (6.4-9.8) |
7.6 (6.0-9.6) |
7.6 (6.6-9.8) |
0.276 |
| eGFR (mL/min) |
71.0 (±21.8) |
79.4 (±19.4) |
63.9 (±21.3) |
<0.001 |
|
TOAST | ||||
| Small vessel |
65 (22.6) |
37 (28.2) |
28 (17.9) |
0.038 |
| Large artery |
51 (17.8) |
23 (17.6) |
28 (17.9) |
0.931 |
| Cardioembolic |
84 (29.3) |
20 (15.3) |
64 (41.0) |
<0.001 |
| Other/ undetermined | 87 (30.3) | 51 (38.9) | 36 (23.1) | 0.004 |
Categorical variables are presented in absolute values with percentages; n (%). Continuous variables are presented as mean (±SD) or median with interquartile range.
hs-cTnT: high sensitivity cardiac troponin T; BP: blood pressure; NIHSS: National Institute of Health Stroke Scale; rt-PA: recombinant tissue plasminogen activator; eGFR: estimated glomerular filtration rate; TOAST: Trial of ORG 10172 in Acute Stroke Treatment.